$NORD
Nordicus Partners Corp

2024 Q3 Form 10-K Financial Statement

#000149315224026126 Filed on July 03, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q1 2024
Revenue $2.500K $2.500K $2.500K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $86.63K $310.1K
YoY Change -96.59%
% of Gross Profit
Research & Development $343.2K
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $509.9K $86.63K $310.1K
YoY Change 426.31% -96.59% -96.34%
Operating Profit -$507.4K -$307.6K
YoY Change 423.73% -96.37%
Interest Expense $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net -$1.00 $0.00 $9.386K
YoY Change -99.95% -100.0% 22.33%
Pretax Income -$507.4K -$84.13K -$298.2K
YoY Change 413.61% -96.69% -96.48%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$500.8K -$84.13K -$298.2K
YoY Change 406.92% -96.69% -96.48%
Net Earnings / Revenue -20031.4% -3365.2% -11928.08%
Basic Earnings Per Share -$0.10 -$0.03
Diluted Earnings Per Share -$0.10 -$0.01 -$0.03
COMMON SHARES
Basic Shares Outstanding 49.46M shares 11.03M shares 10.35M shares
Diluted Shares Outstanding 4.960M shares 10.35M shares

Balance Sheet

Concept 2024 Q3 2024 Q1 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments $49.93K $49.93K
YoY Change 598.32% 598.32%
Cash & Equivalents $46.13K $49.93K
Short-Term Investments
Other Short-Term Assets $0.00 $0.00
YoY Change -100.0% -100.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $118.5K $49.93K $49.93K
YoY Change 999.79% -4.71% -4.71%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $18.64M
YoY Change
Intangibles $223.3K $0.00
YoY Change
Long-Term Investments $1.750M $1.750M
YoY Change
Other Assets $7.640K
YoY Change 191.05%
Total Long-Term Assets $20.67M $1.758M $1.758M
YoY Change 1077.37% 66857.71% 66730.42%
TOTAL ASSETS
Total Short-Term Assets $118.5K $49.93K $49.93K
Total Long-Term Assets $20.67M $1.758M $1.758M
Total Assets $20.79M $1.808M $1.808M
YoY Change 1076.9% 3185.0% 3184.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.020K $5.020K
YoY Change -62.76% -62.76%
Accrued Expenses
YoY Change
Deferred Revenue $7.500K $7.500K
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $152.9K $26.41K $26.41K
YoY Change 495.0% -3.52% -3.51%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $152.9K $26.41K $26.41K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $152.9K $26.41K $26.41K
YoY Change 495.0% -3.52% -3.51%
SHAREHOLDERS EQUITY
Retained Earnings -$44.64M -$43.88M
YoY Change 5.45% 4.0%
Common Stock $4.966K $11.10K
YoY Change -54.34% 33.82%
Preferred Stock
YoY Change
Treasury Stock (at cost) $30.33K $30.33K
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $19.68M $1.781M $1.781M
YoY Change
Total Liabilities & Shareholders Equity $20.79M $1.808M $1.808M
YoY Change 1076.9% 3185.0% 3184.7%

Cashflow Statement

Concept 2024 Q3 2024 Q1 2024
OPERATING ACTIVITIES
Net Income -$500.8K -$84.13K -$298.2K
YoY Change 406.92% -96.69% -96.48%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$107.9K -$258.9K
YoY Change -52.73% -29.71%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 114.4K $305.2K
YoY Change -50.25% 136.82%
NET CHANGE
Cash From Operating Activities -107.9K -$258.9K
Cash From Investing Activities
Cash From Financing Activities 114.4K $305.2K
Net Change In Cash 6.440K $46.30K
YoY Change 318.18% -119.33%
FREE CASH FLOW
Cash From Operating Activities -$107.9K -$258.9K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 us-gaap Officers Compensation
OfficersCompensation
usd
CY2024 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2024 dei Amendment Flag
AmendmentFlag
false
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001011060
CY2024Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
usd
CY2023Q1 us-gaap Long Term Investments
LongTermInvestments
usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2024 NORD Consulting Expense
ConsultingExpense
usd
CY2024 us-gaap Interest Expense
InterestExpense
usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
usd
CY2024 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2023 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
usd
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
usd
CY2023 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
usd
CY2023 us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
usd
CY2024 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
CY2024 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
CY2024 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2024 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2024 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023 NORD Deemed Dividend
DeemedDividend
usd
CY2023 us-gaap Stock Issued1
StockIssued1
usd
CY2024Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
true
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Public Float
EntityPublicFloat
5588950 usd
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
49462248 shares
CY2024 dei Auditor Firm
AuditorFirmId
5525
CY2024 dei Auditor Name
AuditorName
Fruci & Associates II, PLLC
CY2024 dei Auditor Location
AuditorLocation
Spokane, Washington
CY2024Q1 us-gaap Cash
Cash
49933 usd
CY2023Q1 us-gaap Cash
Cash
7149 usd
CY2023Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
44481 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
770 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
49933 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
52400 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7640 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2625 usd
CY2024Q1 us-gaap Long Term Investments
LongTermInvestments
1750000 usd
CY2024Q1 us-gaap Assets
Assets
1807573 usd
CY2023Q1 us-gaap Assets
Assets
55025 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5019 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1354 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7500 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
26405 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
27367 usd
CY2024Q1 us-gaap Liabilities
Liabilities
26405 usd
CY2023Q1 us-gaap Liabilities
Liabilities
27367 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11102248 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8296248 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
11102 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
8296 usd
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1534 shares
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1534 shares
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
30328 usd
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
30328 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
45686769 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
42246688 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2848 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
665 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43883527 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-42197663 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1781168 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
27658 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1807573 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
55025 usd
CY2024 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2500 usd
CY2024 us-gaap Officers Compensation
OfficersCompensation
118477 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
8141501 usd
CY2024 us-gaap Professional Fees
ProfessionalFees
137280 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
102286 usd
CY2023 NORD Consulting Expense
ConsultingExpense
39602 usd
CY2024 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
54331 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
196500 usd
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
-307588 usd
CY2023 us-gaap Interest Expense
InterestExpense
382 usd
CY2024 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9386 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8055 usd
CY2024 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9386 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7673 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-298202 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8472216 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-298202 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-8472216 usd
CY2024 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3513 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
665 usd
CY2024 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-301715 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8471551 usd
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.43
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.43
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10347371 shares
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10347371 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5938851 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5938851 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
194511 usd
CY2023 NORD Adjustments To Additional Paid In Capital Stockbased Compensation Fair Value Of Warrants
AdjustmentsToAdditionalPaidInCapitalStockbasedCompensationFairValueOfWarrants
8141501 usd
CY2023 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
48197 usd
CY2023 NORD Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
115000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8471551 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
27658 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
27658 usd
CY2024 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1750000 usd
CY2024 NORD Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
306000 usd
CY2024 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-775 usd
CY2024 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-301715 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1781168 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1781168 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-298202 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-8472216 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
8141501 usd
CY2024 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4245 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3500 usd
CY2024 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-44481 usd
CY2024 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
7500 usd
CY2024 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-12127 usd
CY2024 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3665 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-41132 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-258928 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-368347 usd
CY2024 us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
775 usd
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
40000 usd
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
40000 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
13886 usd
CY2024 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
306000 usd
CY2023 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
115000 usd
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
305225 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
128886 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
46297 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-239461 usd
CY2024 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3513 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
665 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7149 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
245945 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49933 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7149 usd
CY2024 NORD Deemed Dividend
DeemedDividend
1387662 usd
CY2024 us-gaap Stock Issued1
StockIssued1
1750000 usd
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_841_eus-gaap--UseOfEstimates_z33g7GPaIkH5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_867_zv4G5hnWwAg8">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s accounting estimates include the collectability of receivables, useful lives of long-lived assets and recoverability of those assets, impairment in fair value of goodwill.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zxWywd1ucoJ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86B_zYcTdbHbsy6j">Concentration of Credit Risk</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2024 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
6329000 shares
CY2023 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
6635000 shares
CY2024Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2024 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2500 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
7500 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43883527 usd
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024 NORD Preferred Stock Issued And Redeemed Shares
PreferredStockIssuedAndRedeemedShares
500000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2375300 usd
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2313000 usd
CY2024Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2375300 usd
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2313000 usd
CY2024Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
35359000 usd
CY2024 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
NOLs from tax years up to 2017 can be carried forward twenty years

Files In Submission

Name View Source Status
0001493152-24-026126-index-headers.html Edgar Link pending
0001493152-24-026126-index.html Edgar Link pending
0001493152-24-026126.txt Edgar Link pending
0001493152-24-026126-xbrl.zip Edgar Link pending
ex10-10.htm Edgar Link pending
ex10-11.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
form10-k_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
nord-20240331.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
report_001.jpg Edgar Link pending
nord-20240331_cal.xml Edgar Link unprocessable
nord-20240331_def.xml Edgar Link unprocessable
nord-20240331_lab.xml Edgar Link unprocessable
nord-20240331_pre.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable